Authors: Stopeck, AT Jones, A Hersh, EM Thompson, JA Finucane, DM Gutheil, JC Gonzalez, R

Citation: At. Stopeck et al., Phase II study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta 2-microglobulin DNA-liposome complex, in patients with metastatic melanoma, CLIN CANC R, 7(8), 2001, pp. 2285-2291

Authors: Vogel, C Cobleigh, MA Tripathy, D Gutheil, JC Harris, LN Fehrenbacher, L Slamon, DJ Murphy, M Novotny, WF Burchmore, M Shak, S Stewart, SJ

Citation: C. Vogel et al., First-line, single-agent Herceptin (R) (trastuzumab) in metastatic breast cancer: a preliminary report, EUR J CANC, 37, 2001, pp. S25-S29

Authors: Vogel, CL Cobleigh, MA Tripathy, D Gutheil, JC Harris, LN Fehrenbacher, L Slamon, DJ Murphy, M Novotny, WF Burchmore, M Shak, S Stewart, SJ

Citation: Cl. Vogel et al., First-line Herceptin (R) monotherapy in metastatic breast cancer, ONCOL-BASEL, 61, 2001, pp. 37-42

Authors: Gutheil, JC Campbell, TN Pierce, PR Watkins, JD Huse, WD Bodkin, DJ Cheresh, DA

Citation: Jc. Gutheil et al., Targeted antiangiogenic therapy for cancer using vitaxin: A humanized monoclonal antibody to the integrin alpha(nu)beta(3), CLIN CANC R, 6(8), 2000, pp. 3056-3061

Authors: Glantz, MJ LaFollette, S Jaeckle, KA Shapiro, W Swinnen, L Rozental, JR Phuphanich, S Rogers, LR Gutheil, JC Batchelor, T Lyter, D Chamberlain, M Maria, BL Schiffer, C Bashir, R Thomas, D Cowens, W Howell, SB

Citation: Mj. Glantz et al., Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis, J CL ONCOL, 17(10), 1999, pp. 3110-3116